These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13106889)

  • 21. The medical management of arterial hypertension.
    MEILMAN E
    N Engl J Med; 1953 May; 248(22):936-43; concl. PubMed ID: 13046648
    [No Abstract]   [Full Text] [Related]  

  • 22. Newer drugs in the treatment of hypertension. II. Use of hexamethonium in combination with hydralazine.
    RAST CL; ORGAIN ES; MULLER JC; PRYOR WW; SIEBER HA
    Circulation; 1955 Sep; 12(3):361-9. PubMed ID: 13250698
    [No Abstract]   [Full Text] [Related]  

  • 23. Results with oral hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the therapy of hypertension.
    MOYER JH; SNYDER BH; JOHNSON I; MILLS LC; MILLER SI
    Am J Med Sci; 1953 Apr; 225(4):379-98. PubMed ID: 13030474
    [No Abstract]   [Full Text] [Related]  

  • 24. Observations on the regional circulation during pharmacologically induced hypotension.
    HUEBER EF
    Am J Med Sci; 1955 Jun; 229(6):613-20. PubMed ID: 14376388
    [No Abstract]   [Full Text] [Related]  

  • 25. A preliminary report on clinical experiences with hexamethonium and 1-hydrazinophthalazine in the treatment of diastolic hypertension.
    ROMNEY RB; BULLINGTON RH; ABILDSKOV JA; RAY CT; BURCH GE
    J La State Med Soc; 1953 Apr; 105(4):153-7. PubMed ID: 13053045
    [No Abstract]   [Full Text] [Related]  

  • 26. Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
    STEEVES LC; SHEARS AH; SPELLER SL
    Treat Serv Bull; 1953 Oct; 8(9):573-8. PubMed ID: 13102592
    [No Abstract]   [Full Text] [Related]  

  • 27. The drug treatment of severe hypertensive disease, with particular reference to hydralazine and pentapyrrolidinium.
    HOOBLER SW
    Trans Am Coll Cardiol; 1955 Dec; 5():101-6. PubMed ID: 13274398
    [No Abstract]   [Full Text] [Related]  

  • 28. Further observations on the effects of autonomic blocking agents in patients with hypertension. I. General systemic effects of hexamethonium, pentamethonium, and hydrazinophthalazine.
    GROB D; LANGFORD HG
    Circulation; 1953 Aug; 8(2):20. PubMed ID: 13067201
    [No Abstract]   [Full Text] [Related]  

  • 29. Inquiry into role of antihypertensive drugs.
    SCHISSEL DJ; LARSON E
    AMA Arch Intern Med; 1954 Sep; 94(3):438-42. PubMed ID: 13196726
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug treatment of hypertension.
    HOOBLER SW; DONTAS AS
    Pharmacol Rev; 1953 Jun; 5(2):135-74. PubMed ID: 13064031
    [No Abstract]   [Full Text] [Related]  

  • 31. Some reactions to apresoline, hexamethonium and hydergine.
    SOTO ROJAS G; HERRMANN GR
    Arch Inst Cardiol Mex; 1952 Oct; 22(5):691-708. PubMed ID: 13031877
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium.
    HUGHES WM; DENNIS E; MOYER JH
    Am J Med Sci; 1955 Feb; 229(2):121-34. PubMed ID: 13228421
    [No Abstract]   [Full Text] [Related]  

  • 33. A critical evaluation of the hypotensive asction of hydrallazine, hexamethonium, tetraethylammonium and dibenzyline salts in human and experimental hypertension.
    SHAPIRO AP; GROLLMAN A
    Circulation; 1953 Aug; 8(2):188-98. PubMed ID: 13067199
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the effects of veratrum alkaloids and of hexamethonium bromide upon the blood pressure in arterial hypertension.
    SMIRK FH; CHAPMAN OW
    Am Heart J; 1952 Apr; 43(4):586-605. PubMed ID: 14914714
    [No Abstract]   [Full Text] [Related]  

  • 35. New antihypertension drugs.
    SCHROEDER HA
    J Am Med Assoc; 1952 May; 149(3):297. PubMed ID: 14927346
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of pentolinium tartrate with and without hydralazine in the treatment of severe hypertension.
    PERRY HM; SCHROEDER HA
    N Engl J Med; 1955 Jun; 252(25):1057-66. PubMed ID: 14383963
    [No Abstract]   [Full Text] [Related]  

  • 37. The management of essential hypertension.
    EVANS JM
    Med Ann Dist Columbia; 1953 Sep; 22(9):456-8. PubMed ID: 13085968
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hexamethonium, apresoline and pyretotherapy in the treatment of arterial hypertension].
    THOMSEN P; ORTUZAR R; GONI F
    Rev Med Chil; 1954 Mar; 82(3):119-24. PubMed ID: 13186419
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.
    ORGAIN ES; RAST CL; SIEBER HA
    Trans Am Clin Climatol Assoc; 1953; 65():279-93. PubMed ID: 13205635
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine.
    PAGE IH
    J Med Assoc Ga; 1953 Feb; 42(2):78-81. PubMed ID: 13023272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.